The Estée Lauder Companies Reports Fiscal 2026 First Quarter Results
30 oktober, 11:00
30 oktober, 11:00
The Estée Lauder Companies Inc. (NYSE: EL) today reported its financial results for the first quarter ended September 30, 2025.
“We had a strong start to fiscal 2026 as we execute on our Beauty Reimagined strategy—returning to organic sales growth, gaining prestige beauty share in a few key strategic areas of focus, and improving profitability. Encouragingly, we are building momentum across the organization from the significant operational changes we have executed to-date to be faster and more agile,” said Stéphane de La Faverie, President and CEO. “These results reinforce the confidence we have in our fiscal 2026 outlook—a pivotal year—as we restore organic sales growth and expand our operating margin for the first time in four years.”
FISCAL 2026 FIRST QUARTER SELECT FINANCIAL RESULTS (unaudited)1,2,3
Three Months Ended | Percentage | |||||||
($ in millions, except per share data) | 2025 | 2024 | ||||||
Net Sales | $ | 3,481 | $ | 3,361 | 4 | % | ||
Organic Net Sales, Non-GAAP1,2 | $ | 3,455 | $ | 3,361 | 3 | % | ||
Other Financial Results: | ||||||||
Gross Profit | $ | 2,554 | $ | 2,433 | 5 | % | ||
Gross Margin | 73.4 | % | 72.4 | % | ||||
Adjusted Gross Profit, Non-GAAP1,3 | $ | 2,551 | $ | 2,442 | 4 | % | ||
Adjusted Gross Margin, Non-GAAP1,3 | 73.3 | % | 72.7 | % | ||||
Operating Income (Loss) | $ | 169 | $ | (121 | ) | 100 | +% | |
Operating Margin | 4.9 | % | (3.6 | )% | ||||
Adjusted Operating Income, Non-GAAP1,3 | $ | 255 | $ | 144 | 77 | % | ||
Adjusted Operating Margin, Non-GAAP1,3 | 7.3 | % | 4.3 | % | ||||
Diluted Net Earnings (Loss) Per Common Share | $ | .13 | $ | (.43 | ) | 100 | +% | |
Adjusted Diluted Net Earnings Per Common Share, Non-GAAP1,3 | $ | .32 | $ | .14 | 100 | +% |
________________________________________ |
1See pages 16 and 17 for reconciliation between GAAP and Adjusted Non-GAAP measures. |
2Organic net sales represents net sales excluding returns associated with restructuring and other activities; non-comparable impacts of acquisitions, divestitures and brand closures; as well as the impact from foreign currency translation. The Company believes that the Non-GAAP measure of organic net sales growth provides year-over-year sales comparisons on a consistent basis. |
3Adjusted Non-GAAP measures are calculated based on Net Sales adjusted only for Returns associated with restructuring and other activities. |
________________________________________ |
4Consumer-facing investments includes co-operative advertising, selling, advertising and promotional expenses, as well as store operating costs. |
BEAUTY GAINS AND OPERATIONAL HIGHLIGHTS5
________________________________________ |
5Since the Company’s last earnings announcement, including some previously disclosed. |
6Source: Circana, LLC, US Prestige Beauty Total Department/Specialty, Dollar Share Growth of Corporation, three-months ended September 30, 2025. |
FISCAL 2026 FIRST QUARTER RESULTS BY PRODUCT CATEGORY AND BY REGION
Results by Product Category | ||||||||||||||||||||
Three Months Ended September 30 | ||||||||||||||||||||
Net Sales | Percentage Change1 | Operating | Percentage | |||||||||||||||||
($ in millions) | 2025 | 2024 | Reported | Impact of | Organic | 2025 | 2024 | Reported | ||||||||||||
Skin Care | $ | 1,575 | $ | 1,529 | 3 | % | — | % | 3 | % | $ | 187 | $ | 117 | 60 | % | ||||
Makeup | 1,030 | 1,038 | (1 | ) | (1 | ) | (2 | ) | (15 | ) | (185 | ) | 92 | |||||||
Fragrance | 721 | 630 | 14 | (1 | ) | 13 | 86 | 60 | 43 | |||||||||||
Hair Care | 129 | 139 | (7 | ) | — | (7 | ) | (12 | ) | (18 | ) | 33 | ||||||||
Other | 25 | 25 | — | — | — | 9 | 11 | (18 | ) | |||||||||||
Subtotal | $ | 3,480 | $ | 3,361 | 4 | % | (1 | )% | 3 | % | $ | 255 | $ | (15 | ) | 100 | +% | |||
Returns/charges | ||||||||||||||||||||
associated with | ||||||||||||||||||||
restructuring and | ||||||||||||||||||||
other activities | 1 | — | (86 | ) | (106 | ) | ||||||||||||||
Total | $ | 3,481 | $ | 3,361 | 4 | % | (1 | )% | 3 | % | $ | 169 | $ | (121 | ) | 100 | +% | |||
Non-GAAP Adjustments to As Reported Operating Income (Loss): | ||||||||||||||||||||
Returns/charges associated with restructuring and other activities | 86 | 106 | ||||||||||||||||||
Makeup - Talcum litigation settlement agreements | — | 159 | ||||||||||||||||||
Adjusted Operating Income - Non-GAAP | $ | 255 | $ | 144 | 77 | % | ||||||||||||||
1Percentages are calculated on an individual basis. |
The product category net sales commentary below reflects organic net sales, excluding the impacts from foreign currency translation. In addition to the Operational Highlights above, below are the drivers of the Company’s performance.
Skin Care
Makeup
Fragrance
Hair Care
As previously disclosed by the Company in its Annual Report on Form 10-K for the fiscal year ended June 30, 2025, to enhance accountability and streamline operations within the organization, as well as to align with its previously announced leadership changes, the Company has reorganized its geographic regions. Beginning with the Company's fiscal 2026 first quarter, the Company will be reporting its fiscal 2026 and comparative fiscal 2025 results by geographic region under the new regional structure. The Company's four geographic regions, effective July 1, 2025, are:
In connection with the reorganization of the Company's geographic regions, the Company has changed its methodology used to report certain global and regional activity to reflect management's view of the business. The primary revisions to operating results by region include (i) excluding the impacts of intercompany royalty activities globally, (ii) the allocation of corporate expenses to all regions, including global support functions, which had historically been reported in The Americas region, and (iii) the allocation of impacts from the Company's manufacturing facilities to all regions, which had historically been reported in the region where the facilities are located. These changes were made to reflect management's view that these activities are conducted to benefit the Company on a global basis.
Results by Geographic Region | ||||||||||||||||||||
Three Months Ended September 30 | ||||||||||||||||||||
Net Sales | Percentage Change1 | Operating Income (Loss)2 | Percentage Change | |||||||||||||||||
($ in millions) | 2025 | 2024 | Reported Basis | Impact of Foreign Currency Translation | Organic Net Sales (Non-GAAP) | 2025 | 2024 | Reported Basis | ||||||||||||
The Americas | $ | 1,174 | $ | 1,197 | (2 | )% | — | % | (2 | )% | $ | 87 | $ | (85 | ) | 100 | +% | |||
EUKEM | 901 | 868 | 4 | (4 | ) | — | 6 | 10 | (40 | ) | ||||||||||
Asia/Pacific | 873 | 806 | 8 | — | 9 | 150 | 76 | 97 | ||||||||||||
Mainland China | 532 | 490 | 9 | — | 9 | 12 | (16 | ) | 100 | + | ||||||||||
Subtotal | $ | 3,480 | $ | 3,361 | 4 | % | (1 | )% | 3 | % | $ | 255 | $ | (15 | ) | 100 | +% | |||
Returns/charges | ||||||||||||||||||||
associated with | ||||||||||||||||||||
restructuring and other | ||||||||||||||||||||
activities | 1 | — | (86 | ) | (106 | ) | ||||||||||||||
Total | $ | 3,481 | $ | 3,361 | 4 | % | (1 | )% | 3 | % | $ | 169 | $ | (121 | ) | 100 | +% | |||
Non-GAAP Adjustments to As Reported Operating Income (Loss): | ||||||||||||||||||||
Returns/charges associated with restructuring and other activities | 86 | 106 | ||||||||||||||||||
The Americas - Talcum litigation settlement agreements | — | 159 | ||||||||||||||||||
Adjusted Operating Income - Non-GAAP | $ | 255 | $ | 144 | 77 | % | ||||||||||||||
1Percentages are calculated on an individual basis. | ||||||||||||||||||||
2Operating results by geographic region for the fiscal 2025 first quarter have been adjusted to reflect the correction of a regional misclassification in the amounts furnished in the Form 8-K on October 2, 2025 related to a one-time charge during the fiscal 2025 first quarter. The misclassification was offset in the fiscal 2025 second quarter (quarter-to-date period) furnished amounts. Refer to recast fiscal 2025 second quarter amounts on page 20.No other periods were impacted and there is no impact on the consolidated financial results or results by product category. |
The geographic region net sales commentary below reflects organic net sales, excluding the impacts from foreign currency translation. In addition to the Operational Highlights above, below are the drivers of the Company’s performance.
Organic Net Sales - increased 3%, led by:
Operating Results - increased, driven by:
QUARTERLY DIVIDEND
Today, the Company announced a quarterly dividend of $.35 per share on its Class A and Class B Common Stock, payable in cash on December 15, 2025 to stockholders of record at the close of business on November 28, 2025.
PROFIT RECOVERY AND GROWTH PLAN (“PRGP”)
Actions under the Company’s PRGP are expected to be substantially completed in fiscal 2027, with a majority of the full run-rate benefits expected to be realized during fiscal 2027. The plan is designed to further transform the Company’s operating model to fund a return to sales growth in fiscal 2026 and restore a solid double-digit adjusted operating margin over the next few years, and continue to mitigate impacts from external volatility.
Restructuring Program Component of the PRGP
Relating specifically to the restructuring program component of the PRGP, once fully implemented, the Company expects to take restructuring and other charges of between $1.2 billion and $1.6 billion, before taxes, consisting of employee-related costs, asset-related costs, contract terminations and other costs associated with implementing these initiatives. The restructuring program is expected to yield annual gross benefits of between $0.8 billion and $1.0 billion, before taxes, to help restore operating margin and also fuel reinvestment in consumer-facing areas to drive sustainable sales growth.
The Company estimates a net reduction in positions of 5,800 to 7,000, including approvals to date. This net reduction takes into account the elimination of positions after retraining and redeployment of certain employees in select areas. Approvals for specific initiatives under this restructuring program, in total, are expected to be completed by the end of fiscal 2026. The restructuring program’s focus includes the (i) reorganization and rightsizing of certain areas, (ii) simplification and acceleration of processes, (iii) outsourcing of select services and (iv) evolution of go-to-market footprint and selling models.
Through September 30, 2025, the Company has recognized total cumulative charges under the restructuring component of the PRGP of $697 million, consisting primarily of employee-related costs, with approximately $87 million recognized in the fiscal 2026 first quarter.
Through October 26, 2025, the Company has approved initiatives totaling cumulative charges of $852 million and a net reduction of over 4,000 positions. Inclusive of approvals through October 26, 2025 and relative to the high end of the total expected ranges, the Company has approved initiatives that account for over 70% of the expected gross benefits, over 50% of the expected charges and nearly 60% of the expected net reduction in positions.
OUTLOOK FOR FISCAL 2026 FULL YEAR
The Company reaffirms its fiscal 2026 full-year outlook.
The Company continues to closely monitor evolving trade policies and enacted tariffs, and its task force has been actively evaluating developments and mitigation strategies to reduce the potential impacts of tariffs. The Company has implemented a range of actions, including leveraging available trade programs and further optimizing its regional manufacturing footprint to bring production closer to the consumer—including through its facility in Japan. These efforts, combined with increased supply chain agility, are helping to offset more than half of the expected impacts and better position the Company to adapt quickly as trade policies continue to evolve.
In terms of enacted tariffs, the Company’s assumption reflects the following incremental rates on its most material flow of goods:
Based on information available and net of planned mitigation actions through October 24, 2025, the Company continues to expect tariff-related headwinds to impact fiscal 2026 profitability by approximately $100 million. This assumption does not reflect any subsequent or future changes. The Company continues to evaluate additional strategies, including further PRGP initiatives and potential pricing actions.
See the Company’s fiscal 2025 fourth quarter Earnings Press Release for other full-year assumptions underlying its fiscal 2026 outlook.
Reconciliation between GAAP and Non-GAAP - Net Sales Growth | ||
Twelve Months Ending | ||
June 30, 2026(F) | ||
As Reported - GAAP | 2% - 5 | % |
Impact of foreign currency translation | 2 | |
Returns associated with restructuring and other activities(1) | — | |
Organic, Non-GAAP | 0% - 3 | % |
(F)Represents forecast, using spot rates as of September 30, 2025. | ||
(1)The net sales growth impact of returns associated with restructuring and other activities includes approvals to date. Additional returns associated with restructuring and other activities are anticipated as initiatives are approved in fiscal 2026. |
Reconciliation between GAAP and Non-GAAP - Diluted Net Earnings (Loss) Per Common Share (“EPS”) | |||||||
Twelve Months Ending | |||||||
June 30 | |||||||
2026(F) | 2025 | Growth | |||||
Forecasted/As Reported EPS - GAAP | $1.39 - $1.65 | $ | (3.15 | ) | 100+ | % | |
Non-GAAP | |||||||
Restructuring and other charges(1) | .45 - .51 | 1.06 | |||||
Goodwill and other intangible asset impairments | — | 2.78 | |||||
U.S. deferred tax asset valuation allowance adjustment | — | .48 | |||||
Talcum litigation settlement agreements(2) | — | .34 | |||||
Forecasted/Adjusted EPS - Non-GAAP | $1.90 - $2.10 | $ | 1.51 | 26% - 39 | % | ||
Impact of foreign currency translation | (.03 | ) | |||||
Forecasted/Adjusted Constant Currency EPS - Non-GAAP | $1.87 - $2.07 | $ | 1.51 | 24% - 37 | % | ||
(F)Represents forecast, using spot rates as of September 30, 2025. | |||||||
(1)The diluted net earnings per common share impact of restructuring and other charges includes approvals to date. Additional restructuring and other charges are anticipated as initiatives are approved in fiscal 2026. | |||||||
(2)No assumptions included in the fiscal 2026 forecast. |
The Company continues to monitor the effects of the global macro environment, including the risk of recession; currency volatility; inflationary pressures; supply chain challenges; social and political issues; competitive pressures; legal and regulatory matters, including the imposition of tariffs and sanctions; geopolitical tensions; and global security issues. The Company is also mindful of inflationary pressures (including those caused by tariffs) on its cost base and is monitoring the impact on consumer preferences, the impact of changes being made in the organization, including those related to Beauty Reimagined and the PRGP, as well as the potential impact of changes expected to be made as part of the PRGP on suppliers, retailers and others, and challenges relating to successfully outsourcing select services.
CONFERENCE CALL AND WEBCAST DETAILS
The Estée Lauder Companies will host a conference call at 8:30 a.m. (ET) today, October 30, 2025 to discuss its results for the fiscal 2026 first quarter. The dial-in number for the call is 877-883-0383 in the U.S. or 412-902-6506 internationally (conference ID number: 1175761).
The call will also be webcast live at http://www.elcompanies.com/investors/events-and-presentations and will be available for replay until November 13, 2025.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
Statements in this press release, in particular those in “Outlook,” as well as remarks by the CEO and other members of management, may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may address the Company’s expectations regarding sales, earnings or other future financial performance and liquidity, other performance measures, product introductions, entry into new geographic regions, information technology initiatives, new methods of sale, the Company’s long-term strategy, restructuring and other charges and resulting cost savings, and future operations or operating results. These statements may contain words like “expect,” “will,” “will likely result,” “would,” “believe,” “estimate,” “planned,” “plans,” “intends,” “may,” “should,” “could,” “anticipate,” “estimate,” “project,” “projected,” “forecast,” and “forecasted” or similar expressions. Although the Company believes that its expectations are based on reasonable assumptions within the bounds of its knowledge of its business and operations, actual results may differ materially from the Company’s expectations. Factors that could cause actual results to differ from expectations include, without limitation:
(1) | increased competitive activity from companies in the skin care, makeup, fragrance and hair care businesses; | |
(2) | the Company’s ability to develop, produce and market new products on which future operating results may depend and to successfully address challenges in the Company’s business; | |
(3) | consolidations, restructurings, bankruptcies and reorganizations in the retail industry causing a decrease in the number of stores that sell the Company’s products, an increase in the ownership concentration within the retail industry, ownership of retailers by the Company’s competitors or ownership of competitors by the Company’s customers that are retailers and the Company’s inability to collect receivables; | |
(4) | destocking and tighter working capital management by retailers; | |
(5) | the success, or changes in timing or scope, of new product launches and the success, or changes in timing or scope, of advertising, sampling and merchandising programs; | |
(6) | shifts in the preferences of consumers as to how they perceive value and where and how they shop; | |
(7) | social, political and economic risks to the Company’s foreign or domestic manufacturing, distribution and retail operations, including changes in foreign investment and trade policies and regulations of the host countries and of the United States; | |
(8) | changes in the laws, regulations and policies (including the interpretations and enforcement thereof) that affect, or will affect, the Company’s business, including those relating to its products or distribution networks, changes in accounting standards, tax laws and regulations, environmental or climate change laws, regulations or accords, trade rules and customs regulations, and the outcome and expense of legal or regulatory proceedings, and any action the Company may take as a result; | |
(9) | foreign currency fluctuations affecting the Company’s results of operations and the value of its foreign assets, the relative prices at which the Company and its foreign competitors sell products in the same markets and the Company’s operating and manufacturing costs outside of the United States; | |
(10) | changes in global or local conditions, including those due to volatility in the global credit and equity markets, government economic policies, natural or man-made disasters, real or perceived epidemics, supply chain challenges, inflation, or increased energy costs, that could affect consumer purchasing, the willingness or ability of consumers to travel and/or purchase the Company’s products while traveling, the financial strength of the Company’s customers, suppliers or other contract counterparties, the Company’s operations, the cost and availability of capital which the Company may need for new equipment, facilities or acquisitions, the returns that the Company is able to generate on its pension assets and the resulting impact on funding obligations, the cost and availability of raw materials and the assumptions underlying the Company’s critical accounting estimates; | |
(11) | shipment delays, commodity pricing, depletion of inventory and increased production costs resulting from disruptions of operations at any of the facilities that manufacture the Company’s products or at the Company’s distribution or inventory centers, including disruptions that may be caused by the implementation of information technology initiatives, or by restructurings; | |
(12) | real estate rates and availability, which may affect the Company’s ability to increase or maintain the number of retail locations at which the Company sells its products and the costs associated with the Company’s other facilities; | |
(13) | changes in product mix to products which are less profitable; | |
(14) | the Company’s ability to acquire, develop or implement new information technology, including operational technology and websites, on a timely basis and within the Company’s cost estimates; to maintain continuous operations of its new and existing information technology; and to secure the data and other information that may be stored in such technologies or other systems or media; | |
(15) | the Company’s ability to capitalize on opportunities for improved efficiency, such as publicly-announced strategies and restructuring and cost-savings initiatives, and to integrate acquired businesses and realize value therefrom; | |
(16) | consequences attributable to local or international conflicts around the world, as well as from any terrorist action, retaliation and the threat of further action or retaliation; | |
(17) | the timing and impact of acquisitions, investments and divestitures; and | |
(18) | additional factors as described in the Company’s filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the fiscal year ended June 30, 2025. |
The Company assumes no responsibility to update forward-looking statements made herein or otherwise.
The Estée Lauder Companies Inc. is one of the world’s leading manufacturers, marketers and sellers of quality skin care, makeup, fragrance and hair care products, and is a steward of luxury and prestige brands globally. The Company’s products are sold in approximately 150 countries and territories under brand names including: Estée Lauder, Aramis, Clinique, Lab Series, Origins, M·A·C, La Mer, Bobbi Brown Cosmetics, Aveda, Jo Malone London, Bumble and bumble, Darphin Paris, TOM FORD, Smashbox, AERIN Beauty, Le Labo, Editions de Parfums Frédéric Malle, GLAMGLOW, KILIAN PARIS, Too Faced, Dr.Jart+, the DECIEM family of brands, including The Ordinary and NIOD, and BALMAIN Beauty.
ELC-F
ELC-E
CONSOLIDATED STATEMENT OF EARNINGS (LOSS) | ||||||||
Three Months Ended | Percentage | |||||||
($ in millions, except per share data) | 2025 | 2024 | ||||||
Net sales(A) | $ | 3,481 | $ | 3,361 | 4 | % | ||
Cost of sales(A) | 927 | 928 | — | |||||
Gross profit | 2,554 | 2,433 | 5 | |||||
Gross margin | 73.4 | % | 72.4 | % | ||||
Operating expenses | ||||||||
Selling, general and administrative | 2,296 | 2,298 | — | |||||
Restructuring and other charges(A) | 89 | 97 | (8 | ) | ||||
Talcum litigation settlement agreements(B) | — | 159 | (100 | ) | ||||
Total operating expenses | 2,385 | 2,554 | (7 | ) | ||||
Operating expense margin | 68.5 | % | 76.0 | % | ||||
Operating income (loss) | 169 | (121 | ) | 100 | + | |||
Operating income (loss) margin | 4.9 | % | (3.6 | )% | ||||
Interest expense | 86 | 92 | (7 | ) | ||||
Interest income and investment income, net | 30 | 35 | (14 | ) | ||||
Other components of net periodic benefit cost | 4 | 2 | 100 | |||||
Earnings (loss) before income taxes | 109 | (180 | ) | 100 | + | |||
Provision (benefit) for income taxes | 62 | (24 | ) | 100 | + | |||
Net earnings (loss) | $ | 47 | $ | (156 | ) | 100 | + | |
Net earnings (loss) per common share | ||||||||
Basic | $ | .13 | $ | (.43 | ) | 100 | +% | |
Diluted | $ | .13 | $ | (.43 | ) | 100 | +% | |
Weighted-average common shares outstanding | ||||||||
Basic | 361.2 | 359.6 | ||||||
Diluted | 363.3 | 359.6 | ||||||
(A) Included in net sales, cost of sales and restructuring and other charges are the impacts of returns and charges associated with the restructuring program component of the PRGP and the Post-COVID Business Acceleration Program (the “PCBA Program”). Additional information about the restructuring program component of the PRGP and the PCBA Program is included in the notes to consolidated financial statements in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2025. | ||||||||
(B) From the end of August 2024 through October 2024, the Company reached agreements with certain plaintiff law firms (collectively, the “talcum litigation settlement agreements”) for: (i) the resolution of pending cosmetic talcum powder matters handled by those firms as well as (ii) a process for resolving potential future cosmetic talcum powder claims expected to be brought on behalf of plaintiffs by those firms from January 1, 2025 through December 31, 2029, with annual capped amounts per year for each participating law firm. To account for the talcum litigation settlement agreements, the Company recorded a charge of $159 million in the fiscal 2025 first quarter for the amount agreed to settle the current claims and an estimated amount for potential future claims. |
This earnings release includes some non-GAAP financial measures relating to charges associated with restructuring and other activities and adjustments, as well as organic net sales. Included herein are reconciliations between the non-GAAP financial measures and the most directly comparable GAAP measures for certain consolidated statements of earnings (loss) accounts before and after these items. The Company uses certain non-GAAP financial measures, among other financial measures, to evaluate its operating performance, which represent the manner in which the Company conducts and views its business. Management believes that excluding certain items that are not comparable from period-to-period, or do not reflect the Company’s underlying ongoing business, provides transparency for such items and helps investors and others compare and analyze operating performance from period-to-period. In the future, the Company expects to incur charges or adjustments similar in nature to those presented herein; however, the impact to the Company’s results in a given period may be highly variable and difficult to predict. The Company’s non-GAAP financial measures may not be comparable to similarly titled measures used by, or determined in a manner consistent with, other companies. While the Company considers the non-GAAP measures useful in analyzing its results, they are not intended to replace, or act as a substitute for, any presentation included in the consolidated financial statements prepared in conformity with U.S. GAAP.
The Company operates on a global basis, with the majority of its net sales generated outside the United States. Accordingly, fluctuations in foreign currency exchange rates can affect the Company’s results of operations. Therefore, the Company presents certain net sales information excluding the effect of foreign currency rate fluctuations to provide a framework for assessing the performance of its underlying business outside the United States. Constant currency information compares results between periods as if exchange rates had remained constant period-over-period. The Company calculates constant currency information by translating current-period results using prior-year period monthly average foreign currency exchange rates and adjusting for the period-over-period impact of foreign currency cash flow hedging activities.
Reconciliation between GAAP and Non-GAAP Net Sales | ||||||||
Three Months Ended | Percentage | |||||||
($ in millions) | 2025 | 2024 | ||||||
Net Sales | $ | 3,481 | $ | 3,361 | 4 | % | ||
Non-GAAP Adjustments | ||||||||
Returns associated with restructuring and other activities | (1 | ) | — | |||||
Adjusted Net Sales, Non-GAAP | 3,480 | 3,361 | ||||||
Impact of foreign currency translation | (25 | ) | — | |||||
Organic Net Sales, Non-GAAP | $ | 3,455 | $ | 3,361 | 3 | % |
Reconciliation of Certain Consolidated Statements of Earnings (Loss) Accounts | ||||||||
Three Months Ended | Percentage | |||||||
($ in millions, except per share data) | 2025 | 2024 | ||||||
Gross Profit | $ | 2,554 | $ | 2,433 | 5 | % | ||
Non-GAAP Adjustments | ||||||||
Restructuring and other activities | (3 | ) | 9 | |||||
Adjusted Gross Profit, Non-GAAP | $ | 2,551 | $ | 2,442 | 4 | % | ||
Gross Margin | 73.4 | % | 72.4 | % | ||||
Non-GAAP Adjustments | ||||||||
Restructuring and other activities | (0.1 | ) | 0.3 | |||||
Adjusted Gross Margin, Non-GAAP | 73.3 | % | 72.7 | % | ||||
Operating Income (Loss) | $ | 169 | $ | (121 | ) | 100 | +% | |
Non-GAAP Adjustments | ||||||||
Restructuring and other charges | 86 | 106 | ||||||
Talcum litigation settlement agreements | — | 159 | ||||||
Adjusted Operating Income, Non-GAAP | $ | 255 | $ | 144 | 77 | % | ||
Operating Margin | 4.9 | % | (3.6 | )% | ||||
Non-GAAP Adjustments | ||||||||
Restructuring and other charges | 2.4 | 3.2 | ||||||
Talcum litigation settlement agreements | — | 4.7 | ||||||
Adjusted Operating Margin, Non-GAAP | 7.3 | % | 4.3 | % | ||||
Provision (benefit) for Income Taxes | $ | 62 | $ | (24 | ) | 100 | +% | |
Effective Tax Rate ("ETR") | 56.9 | % | 13.3 | % | ||||
Tax Impact on Non-GAAP adjustments | ||||||||
Restructuring and other charges | 17 | 22 | ||||||
Talcum litigation settlement agreements | — | 35 | ||||||
Adjusted Provision for Income Taxes, Non-GAAP | $ | 79 | $ | 33 | ||||
Adjusted ETR, Non-GAAP | 40.5 | % | 38.8 | % | ||||
Diluted Net Earnings (Loss) Per Common Share | .13 | (.43 | ) | 100 | +% | |||
Non-GAAP Adjustments | ||||||||
Restructuring and other charges | .19 | .23 | ||||||
Talcum litigation settlement agreements | — | .34 | ||||||
Adjusted Diluted Net Earnings Per Common Share, Non-GAAP2 | $ | .32 | $ | .14 | 100 | +% | ||
1Percentages are calculated on an individual basis. | ||||||||
2For the three months ended September 30, 2024, the effects of potentially dilutive stock options, performance share units, and restricted stock units of approximately 1.2 million shares were excluded from the computation of As Reported and adjustments to Non-GAAP diluted loss per common share as they were anti-dilutive due to the net loss incurred during the period. These shares were added to the weighted-average common shares outstanding to calculate Non-GAAP diluted net earnings per common share. |
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited, except where noted) | |||||||||
September 30, | June 30, | September 30, | |||||||
($ in millions) | (Audited) | ||||||||
ASSETS | |||||||||
Cash and cash equivalents | $ | 2,219 | $ | 2,921 | $ | 2,350 | |||
Accounts receivable, net | 1,884 | 1,530 | 1,977 | ||||||
Inventory and promotional merchandise | 2,062 | 2,074 | 2,255 | ||||||
Prepaid expenses and other current assets | 549 | 544 | 633 | ||||||
Total current assets | 6,714 | 7,069 | 7,215 | ||||||
Property, plant and equipment, net | 3,065 | 3,172 | 3,233 | ||||||
Operating lease right-of-use assets | 1,889 | 1,952 | 1,973 | ||||||
Other assets | 7,661 | 7,699 | 8,896 | ||||||
Total assets | $ | 19,329 | $ | 19,892 | $ | 21,317 | |||
LIABILITIES AND EQUITY | |||||||||
Current debt | $ | 3 | $ | 3 | $ | 504 | |||
Accounts payable | 1,289 | 1,497 | 1,135 | ||||||
Operating lease liabilities | 415 | 406 | 393 | ||||||
Other accrued liabilities | 3,376 | 3,529 | 3,454 | ||||||
Total current liabilities | 5,083 | 5,435 | 5,486 | ||||||
Long-term debt | 7,320 | 7,314 | 7,311 | ||||||
Long-term operating lease liabilities | 1,684 | 1,744 | 1,802 | ||||||
Other noncurrent liabilities | 1,352 | 1,534 | 1,634 | ||||||
Total noncurrent liabilities | 10,356 | 10,592 | 10,747 | ||||||
Total equity | 3,890 | 3,865 | 5,084 | ||||||
Total liabilities and equity | $ | 19,329 | $ | 19,892 | $ | 21,317 |
SELECT CASH FLOW DATA | ||||||
Three Months Ended | ||||||
($ in millions) | 2025 | 2024 | ||||
Net earnings (loss) | $ | 47 | $ | (156 | ) | |
Adjustments to reconcile net earnings (loss) to net cash flows from operating activities: | ||||||
Depreciation and amortization | 200 | 208 | ||||
Deferred income taxes | (34 | ) | (79 | ) | ||
Other items | 82 | 73 | ||||
Changes in operating assets and liabilities: | ||||||
Increase in accounts receivable, net | (358 | ) | (219 | ) | ||
Decrease (increase) in inventory and promotional merchandise | 6 | (10 | ) | |||
Increase in other assets, net | (11 | ) | (47 | ) | ||
Decrease in accounts payable and other liabilities, net | (272 | ) | (440 | ) | ||
Net cash flows used for operating activities | $ | (340 | ) | $ | (670 | ) |
Other Investing and Financing Uses: | ||||||
Capital expenditures | $ | (96 | ) | $ | (141 | ) |
Dividends paid to stockholders | (127 | ) | (240 | ) | ||
Payment of deferred consideration | (150 | ) | — | |||
Supplemental cash flow information: | ||||||
Cash paid for interest | $ | 62 | $ | 63 | ||
Cash paid for income taxes | 148 | 195 |
Operating results by geographic region for the fiscal 2025 first quarter, as presented above, have been adjusted to reflect the correction of a regional misclassification in the amounts furnished in the Form 8-K on October 2, 2025 related to a one-time charge during the fiscal 2025 first quarter. The misclassification was offset in the fiscal 2025 second quarter (quarter-to-date period) furnished amounts, and the adjusted amounts are presented below. No other periods were impacted and there is no impact on the consolidated financial results or results by product category.
Results by Geographic Region | ||||||||||||||||||||
Three Months Ended December 31 | ||||||||||||||||||||
Net Sales | Percentage Change1 | Operating (Loss) | Percentage | |||||||||||||||||
($ in millions) | 2024 | 2023 | Reported | Impact of | Organic | 2024 | 2023 | Reported | ||||||||||||
The Americas | $ | 1,209 | $ | 1,239 | (2 | )% | 1 | % | (1 | )% | $ | (771 | ) | $ | 145 | (100 | +)% | |||
EUKEM | 1,085 | 1,064 | 2 | — | 2 | 145 | 103 | 41 | ||||||||||||
Asia/Pacific | 888 | 1,069 | (17 | ) | 1 | (16 | ) | 152 | 214 | (29 | ) | |||||||||
Mainland China | 822 | 908 | (9 | ) | (1 | ) | (10 | ) | 75 | 120 | (38 | ) | ||||||||
Subtotal | $ | 4,004 | $ | 4,280 | (6 | )% | — | % | (6 | )% | $ | (399 | ) | $ | 582 | (100 | +)% | |||
Returns/charges | ||||||||||||||||||||
associated with | ||||||||||||||||||||
restructuring and | ||||||||||||||||||||
other activities | — | (1 | ) | (181 | ) | (8 | ) | |||||||||||||
Total | $ | 4,004 | $ | 4,279 | (6 | )% | — | % | (6 | )% | $ | (580 | ) | $ | 574 | (100 | +)% | |||
Non-GAAP Adjustments to As Reported Operating (Loss) Income: | ||||||||||||||||||||
Returns/charges associated with restructuring and other activities | 181 | 8 | ||||||||||||||||||
The Americas - Goodwill and other intangible asset impairments | 861 | — | ||||||||||||||||||
The Americas - Change in fair value of DECIEM acquisition-related stock options | — | (5 | ) | |||||||||||||||||
Adjusted Operating Income - Non-GAAP | $ | 462 | $ | 577 | (20 | )% | ||||||||||||||
1Percentages are calculated on an individual basis. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20251030442112/en/
30 oktober, 11:00
The Estée Lauder Companies Inc. (NYSE: EL) today reported its financial results for the first quarter ended September 30, 2025.
“We had a strong start to fiscal 2026 as we execute on our Beauty Reimagined strategy—returning to organic sales growth, gaining prestige beauty share in a few key strategic areas of focus, and improving profitability. Encouragingly, we are building momentum across the organization from the significant operational changes we have executed to-date to be faster and more agile,” said Stéphane de La Faverie, President and CEO. “These results reinforce the confidence we have in our fiscal 2026 outlook—a pivotal year—as we restore organic sales growth and expand our operating margin for the first time in four years.”
FISCAL 2026 FIRST QUARTER SELECT FINANCIAL RESULTS (unaudited)1,2,3
Three Months Ended | Percentage | |||||||
($ in millions, except per share data) | 2025 | 2024 | ||||||
Net Sales | $ | 3,481 | $ | 3,361 | 4 | % | ||
Organic Net Sales, Non-GAAP1,2 | $ | 3,455 | $ | 3,361 | 3 | % | ||
Other Financial Results: | ||||||||
Gross Profit | $ | 2,554 | $ | 2,433 | 5 | % | ||
Gross Margin | 73.4 | % | 72.4 | % | ||||
Adjusted Gross Profit, Non-GAAP1,3 | $ | 2,551 | $ | 2,442 | 4 | % | ||
Adjusted Gross Margin, Non-GAAP1,3 | 73.3 | % | 72.7 | % | ||||
Operating Income (Loss) | $ | 169 | $ | (121 | ) | 100 | +% | |
Operating Margin | 4.9 | % | (3.6 | )% | ||||
Adjusted Operating Income, Non-GAAP1,3 | $ | 255 | $ | 144 | 77 | % | ||
Adjusted Operating Margin, Non-GAAP1,3 | 7.3 | % | 4.3 | % | ||||
Diluted Net Earnings (Loss) Per Common Share | $ | .13 | $ | (.43 | ) | 100 | +% | |
Adjusted Diluted Net Earnings Per Common Share, Non-GAAP1,3 | $ | .32 | $ | .14 | 100 | +% |
________________________________________ |
1See pages 16 and 17 for reconciliation between GAAP and Adjusted Non-GAAP measures. |
2Organic net sales represents net sales excluding returns associated with restructuring and other activities; non-comparable impacts of acquisitions, divestitures and brand closures; as well as the impact from foreign currency translation. The Company believes that the Non-GAAP measure of organic net sales growth provides year-over-year sales comparisons on a consistent basis. |
3Adjusted Non-GAAP measures are calculated based on Net Sales adjusted only for Returns associated with restructuring and other activities. |
________________________________________ |
4Consumer-facing investments includes co-operative advertising, selling, advertising and promotional expenses, as well as store operating costs. |
BEAUTY GAINS AND OPERATIONAL HIGHLIGHTS5
________________________________________ |
5Since the Company’s last earnings announcement, including some previously disclosed. |
6Source: Circana, LLC, US Prestige Beauty Total Department/Specialty, Dollar Share Growth of Corporation, three-months ended September 30, 2025. |
FISCAL 2026 FIRST QUARTER RESULTS BY PRODUCT CATEGORY AND BY REGION
Results by Product Category | ||||||||||||||||||||
Three Months Ended September 30 | ||||||||||||||||||||
Net Sales | Percentage Change1 | Operating | Percentage | |||||||||||||||||
($ in millions) | 2025 | 2024 | Reported | Impact of | Organic | 2025 | 2024 | Reported | ||||||||||||
Skin Care | $ | 1,575 | $ | 1,529 | 3 | % | — | % | 3 | % | $ | 187 | $ | 117 | 60 | % | ||||
Makeup | 1,030 | 1,038 | (1 | ) | (1 | ) | (2 | ) | (15 | ) | (185 | ) | 92 | |||||||
Fragrance | 721 | 630 | 14 | (1 | ) | 13 | 86 | 60 | 43 | |||||||||||
Hair Care | 129 | 139 | (7 | ) | — | (7 | ) | (12 | ) | (18 | ) | 33 | ||||||||
Other | 25 | 25 | — | — | — | 9 | 11 | (18 | ) | |||||||||||
Subtotal | $ | 3,480 | $ | 3,361 | 4 | % | (1 | )% | 3 | % | $ | 255 | $ | (15 | ) | 100 | +% | |||
Returns/charges | ||||||||||||||||||||
associated with | ||||||||||||||||||||
restructuring and | ||||||||||||||||||||
other activities | 1 | — | (86 | ) | (106 | ) | ||||||||||||||
Total | $ | 3,481 | $ | 3,361 | 4 | % | (1 | )% | 3 | % | $ | 169 | $ | (121 | ) | 100 | +% | |||
Non-GAAP Adjustments to As Reported Operating Income (Loss): | ||||||||||||||||||||
Returns/charges associated with restructuring and other activities | 86 | 106 | ||||||||||||||||||
Makeup - Talcum litigation settlement agreements | — | 159 | ||||||||||||||||||
Adjusted Operating Income - Non-GAAP | $ | 255 | $ | 144 | 77 | % | ||||||||||||||
1Percentages are calculated on an individual basis. |
The product category net sales commentary below reflects organic net sales, excluding the impacts from foreign currency translation. In addition to the Operational Highlights above, below are the drivers of the Company’s performance.
Skin Care
Makeup
Fragrance
Hair Care
As previously disclosed by the Company in its Annual Report on Form 10-K for the fiscal year ended June 30, 2025, to enhance accountability and streamline operations within the organization, as well as to align with its previously announced leadership changes, the Company has reorganized its geographic regions. Beginning with the Company's fiscal 2026 first quarter, the Company will be reporting its fiscal 2026 and comparative fiscal 2025 results by geographic region under the new regional structure. The Company's four geographic regions, effective July 1, 2025, are:
In connection with the reorganization of the Company's geographic regions, the Company has changed its methodology used to report certain global and regional activity to reflect management's view of the business. The primary revisions to operating results by region include (i) excluding the impacts of intercompany royalty activities globally, (ii) the allocation of corporate expenses to all regions, including global support functions, which had historically been reported in The Americas region, and (iii) the allocation of impacts from the Company's manufacturing facilities to all regions, which had historically been reported in the region where the facilities are located. These changes were made to reflect management's view that these activities are conducted to benefit the Company on a global basis.
Results by Geographic Region | ||||||||||||||||||||
Three Months Ended September 30 | ||||||||||||||||||||
Net Sales | Percentage Change1 | Operating Income (Loss)2 | Percentage Change | |||||||||||||||||
($ in millions) | 2025 | 2024 | Reported Basis | Impact of Foreign Currency Translation | Organic Net Sales (Non-GAAP) | 2025 | 2024 | Reported Basis | ||||||||||||
The Americas | $ | 1,174 | $ | 1,197 | (2 | )% | — | % | (2 | )% | $ | 87 | $ | (85 | ) | 100 | +% | |||
EUKEM | 901 | 868 | 4 | (4 | ) | — | 6 | 10 | (40 | ) | ||||||||||
Asia/Pacific | 873 | 806 | 8 | — | 9 | 150 | 76 | 97 | ||||||||||||
Mainland China | 532 | 490 | 9 | — | 9 | 12 | (16 | ) | 100 | + | ||||||||||
Subtotal | $ | 3,480 | $ | 3,361 | 4 | % | (1 | )% | 3 | % | $ | 255 | $ | (15 | ) | 100 | +% | |||
Returns/charges | ||||||||||||||||||||
associated with | ||||||||||||||||||||
restructuring and other | ||||||||||||||||||||
activities | 1 | — | (86 | ) | (106 | ) | ||||||||||||||
Total | $ | 3,481 | $ | 3,361 | 4 | % | (1 | )% | 3 | % | $ | 169 | $ | (121 | ) | 100 | +% | |||
Non-GAAP Adjustments to As Reported Operating Income (Loss): | ||||||||||||||||||||
Returns/charges associated with restructuring and other activities | 86 | 106 | ||||||||||||||||||
The Americas - Talcum litigation settlement agreements | — | 159 | ||||||||||||||||||
Adjusted Operating Income - Non-GAAP | $ | 255 | $ | 144 | 77 | % | ||||||||||||||
1Percentages are calculated on an individual basis. | ||||||||||||||||||||
2Operating results by geographic region for the fiscal 2025 first quarter have been adjusted to reflect the correction of a regional misclassification in the amounts furnished in the Form 8-K on October 2, 2025 related to a one-time charge during the fiscal 2025 first quarter. The misclassification was offset in the fiscal 2025 second quarter (quarter-to-date period) furnished amounts. Refer to recast fiscal 2025 second quarter amounts on page 20.No other periods were impacted and there is no impact on the consolidated financial results or results by product category. |
The geographic region net sales commentary below reflects organic net sales, excluding the impacts from foreign currency translation. In addition to the Operational Highlights above, below are the drivers of the Company’s performance.
Organic Net Sales - increased 3%, led by:
Operating Results - increased, driven by:
QUARTERLY DIVIDEND
Today, the Company announced a quarterly dividend of $.35 per share on its Class A and Class B Common Stock, payable in cash on December 15, 2025 to stockholders of record at the close of business on November 28, 2025.
PROFIT RECOVERY AND GROWTH PLAN (“PRGP”)
Actions under the Company’s PRGP are expected to be substantially completed in fiscal 2027, with a majority of the full run-rate benefits expected to be realized during fiscal 2027. The plan is designed to further transform the Company’s operating model to fund a return to sales growth in fiscal 2026 and restore a solid double-digit adjusted operating margin over the next few years, and continue to mitigate impacts from external volatility.
Restructuring Program Component of the PRGP
Relating specifically to the restructuring program component of the PRGP, once fully implemented, the Company expects to take restructuring and other charges of between $1.2 billion and $1.6 billion, before taxes, consisting of employee-related costs, asset-related costs, contract terminations and other costs associated with implementing these initiatives. The restructuring program is expected to yield annual gross benefits of between $0.8 billion and $1.0 billion, before taxes, to help restore operating margin and also fuel reinvestment in consumer-facing areas to drive sustainable sales growth.
The Company estimates a net reduction in positions of 5,800 to 7,000, including approvals to date. This net reduction takes into account the elimination of positions after retraining and redeployment of certain employees in select areas. Approvals for specific initiatives under this restructuring program, in total, are expected to be completed by the end of fiscal 2026. The restructuring program’s focus includes the (i) reorganization and rightsizing of certain areas, (ii) simplification and acceleration of processes, (iii) outsourcing of select services and (iv) evolution of go-to-market footprint and selling models.
Through September 30, 2025, the Company has recognized total cumulative charges under the restructuring component of the PRGP of $697 million, consisting primarily of employee-related costs, with approximately $87 million recognized in the fiscal 2026 first quarter.
Through October 26, 2025, the Company has approved initiatives totaling cumulative charges of $852 million and a net reduction of over 4,000 positions. Inclusive of approvals through October 26, 2025 and relative to the high end of the total expected ranges, the Company has approved initiatives that account for over 70% of the expected gross benefits, over 50% of the expected charges and nearly 60% of the expected net reduction in positions.
OUTLOOK FOR FISCAL 2026 FULL YEAR
The Company reaffirms its fiscal 2026 full-year outlook.
The Company continues to closely monitor evolving trade policies and enacted tariffs, and its task force has been actively evaluating developments and mitigation strategies to reduce the potential impacts of tariffs. The Company has implemented a range of actions, including leveraging available trade programs and further optimizing its regional manufacturing footprint to bring production closer to the consumer—including through its facility in Japan. These efforts, combined with increased supply chain agility, are helping to offset more than half of the expected impacts and better position the Company to adapt quickly as trade policies continue to evolve.
In terms of enacted tariffs, the Company’s assumption reflects the following incremental rates on its most material flow of goods:
Based on information available and net of planned mitigation actions through October 24, 2025, the Company continues to expect tariff-related headwinds to impact fiscal 2026 profitability by approximately $100 million. This assumption does not reflect any subsequent or future changes. The Company continues to evaluate additional strategies, including further PRGP initiatives and potential pricing actions.
See the Company’s fiscal 2025 fourth quarter Earnings Press Release for other full-year assumptions underlying its fiscal 2026 outlook.
Reconciliation between GAAP and Non-GAAP - Net Sales Growth | ||
Twelve Months Ending | ||
June 30, 2026(F) | ||
As Reported - GAAP | 2% - 5 | % |
Impact of foreign currency translation | 2 | |
Returns associated with restructuring and other activities(1) | — | |
Organic, Non-GAAP | 0% - 3 | % |
(F)Represents forecast, using spot rates as of September 30, 2025. | ||
(1)The net sales growth impact of returns associated with restructuring and other activities includes approvals to date. Additional returns associated with restructuring and other activities are anticipated as initiatives are approved in fiscal 2026. |
Reconciliation between GAAP and Non-GAAP - Diluted Net Earnings (Loss) Per Common Share (“EPS”) | |||||||
Twelve Months Ending | |||||||
June 30 | |||||||
2026(F) | 2025 | Growth | |||||
Forecasted/As Reported EPS - GAAP | $1.39 - $1.65 | $ | (3.15 | ) | 100+ | % | |
Non-GAAP | |||||||
Restructuring and other charges(1) | .45 - .51 | 1.06 | |||||
Goodwill and other intangible asset impairments | — | 2.78 | |||||
U.S. deferred tax asset valuation allowance adjustment | — | .48 | |||||
Talcum litigation settlement agreements(2) | — | .34 | |||||
Forecasted/Adjusted EPS - Non-GAAP | $1.90 - $2.10 | $ | 1.51 | 26% - 39 | % | ||
Impact of foreign currency translation | (.03 | ) | |||||
Forecasted/Adjusted Constant Currency EPS - Non-GAAP | $1.87 - $2.07 | $ | 1.51 | 24% - 37 | % | ||
(F)Represents forecast, using spot rates as of September 30, 2025. | |||||||
(1)The diluted net earnings per common share impact of restructuring and other charges includes approvals to date. Additional restructuring and other charges are anticipated as initiatives are approved in fiscal 2026. | |||||||
(2)No assumptions included in the fiscal 2026 forecast. |
The Company continues to monitor the effects of the global macro environment, including the risk of recession; currency volatility; inflationary pressures; supply chain challenges; social and political issues; competitive pressures; legal and regulatory matters, including the imposition of tariffs and sanctions; geopolitical tensions; and global security issues. The Company is also mindful of inflationary pressures (including those caused by tariffs) on its cost base and is monitoring the impact on consumer preferences, the impact of changes being made in the organization, including those related to Beauty Reimagined and the PRGP, as well as the potential impact of changes expected to be made as part of the PRGP on suppliers, retailers and others, and challenges relating to successfully outsourcing select services.
CONFERENCE CALL AND WEBCAST DETAILS
The Estée Lauder Companies will host a conference call at 8:30 a.m. (ET) today, October 30, 2025 to discuss its results for the fiscal 2026 first quarter. The dial-in number for the call is 877-883-0383 in the U.S. or 412-902-6506 internationally (conference ID number: 1175761).
The call will also be webcast live at http://www.elcompanies.com/investors/events-and-presentations and will be available for replay until November 13, 2025.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
Statements in this press release, in particular those in “Outlook,” as well as remarks by the CEO and other members of management, may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may address the Company’s expectations regarding sales, earnings or other future financial performance and liquidity, other performance measures, product introductions, entry into new geographic regions, information technology initiatives, new methods of sale, the Company’s long-term strategy, restructuring and other charges and resulting cost savings, and future operations or operating results. These statements may contain words like “expect,” “will,” “will likely result,” “would,” “believe,” “estimate,” “planned,” “plans,” “intends,” “may,” “should,” “could,” “anticipate,” “estimate,” “project,” “projected,” “forecast,” and “forecasted” or similar expressions. Although the Company believes that its expectations are based on reasonable assumptions within the bounds of its knowledge of its business and operations, actual results may differ materially from the Company’s expectations. Factors that could cause actual results to differ from expectations include, without limitation:
(1) | increased competitive activity from companies in the skin care, makeup, fragrance and hair care businesses; | |
(2) | the Company’s ability to develop, produce and market new products on which future operating results may depend and to successfully address challenges in the Company’s business; | |
(3) | consolidations, restructurings, bankruptcies and reorganizations in the retail industry causing a decrease in the number of stores that sell the Company’s products, an increase in the ownership concentration within the retail industry, ownership of retailers by the Company’s competitors or ownership of competitors by the Company’s customers that are retailers and the Company’s inability to collect receivables; | |
(4) | destocking and tighter working capital management by retailers; | |
(5) | the success, or changes in timing or scope, of new product launches and the success, or changes in timing or scope, of advertising, sampling and merchandising programs; | |
(6) | shifts in the preferences of consumers as to how they perceive value and where and how they shop; | |
(7) | social, political and economic risks to the Company’s foreign or domestic manufacturing, distribution and retail operations, including changes in foreign investment and trade policies and regulations of the host countries and of the United States; | |
(8) | changes in the laws, regulations and policies (including the interpretations and enforcement thereof) that affect, or will affect, the Company’s business, including those relating to its products or distribution networks, changes in accounting standards, tax laws and regulations, environmental or climate change laws, regulations or accords, trade rules and customs regulations, and the outcome and expense of legal or regulatory proceedings, and any action the Company may take as a result; | |
(9) | foreign currency fluctuations affecting the Company’s results of operations and the value of its foreign assets, the relative prices at which the Company and its foreign competitors sell products in the same markets and the Company’s operating and manufacturing costs outside of the United States; | |
(10) | changes in global or local conditions, including those due to volatility in the global credit and equity markets, government economic policies, natural or man-made disasters, real or perceived epidemics, supply chain challenges, inflation, or increased energy costs, that could affect consumer purchasing, the willingness or ability of consumers to travel and/or purchase the Company’s products while traveling, the financial strength of the Company’s customers, suppliers or other contract counterparties, the Company’s operations, the cost and availability of capital which the Company may need for new equipment, facilities or acquisitions, the returns that the Company is able to generate on its pension assets and the resulting impact on funding obligations, the cost and availability of raw materials and the assumptions underlying the Company’s critical accounting estimates; | |
(11) | shipment delays, commodity pricing, depletion of inventory and increased production costs resulting from disruptions of operations at any of the facilities that manufacture the Company’s products or at the Company’s distribution or inventory centers, including disruptions that may be caused by the implementation of information technology initiatives, or by restructurings; | |
(12) | real estate rates and availability, which may affect the Company’s ability to increase or maintain the number of retail locations at which the Company sells its products and the costs associated with the Company’s other facilities; | |
(13) | changes in product mix to products which are less profitable; | |
(14) | the Company’s ability to acquire, develop or implement new information technology, including operational technology and websites, on a timely basis and within the Company’s cost estimates; to maintain continuous operations of its new and existing information technology; and to secure the data and other information that may be stored in such technologies or other systems or media; | |
(15) | the Company’s ability to capitalize on opportunities for improved efficiency, such as publicly-announced strategies and restructuring and cost-savings initiatives, and to integrate acquired businesses and realize value therefrom; | |
(16) | consequences attributable to local or international conflicts around the world, as well as from any terrorist action, retaliation and the threat of further action or retaliation; | |
(17) | the timing and impact of acquisitions, investments and divestitures; and | |
(18) | additional factors as described in the Company’s filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the fiscal year ended June 30, 2025. |
The Company assumes no responsibility to update forward-looking statements made herein or otherwise.
The Estée Lauder Companies Inc. is one of the world’s leading manufacturers, marketers and sellers of quality skin care, makeup, fragrance and hair care products, and is a steward of luxury and prestige brands globally. The Company’s products are sold in approximately 150 countries and territories under brand names including: Estée Lauder, Aramis, Clinique, Lab Series, Origins, M·A·C, La Mer, Bobbi Brown Cosmetics, Aveda, Jo Malone London, Bumble and bumble, Darphin Paris, TOM FORD, Smashbox, AERIN Beauty, Le Labo, Editions de Parfums Frédéric Malle, GLAMGLOW, KILIAN PARIS, Too Faced, Dr.Jart+, the DECIEM family of brands, including The Ordinary and NIOD, and BALMAIN Beauty.
ELC-F
ELC-E
CONSOLIDATED STATEMENT OF EARNINGS (LOSS) | ||||||||
Three Months Ended | Percentage | |||||||
($ in millions, except per share data) | 2025 | 2024 | ||||||
Net sales(A) | $ | 3,481 | $ | 3,361 | 4 | % | ||
Cost of sales(A) | 927 | 928 | — | |||||
Gross profit | 2,554 | 2,433 | 5 | |||||
Gross margin | 73.4 | % | 72.4 | % | ||||
Operating expenses | ||||||||
Selling, general and administrative | 2,296 | 2,298 | — | |||||
Restructuring and other charges(A) | 89 | 97 | (8 | ) | ||||
Talcum litigation settlement agreements(B) | — | 159 | (100 | ) | ||||
Total operating expenses | 2,385 | 2,554 | (7 | ) | ||||
Operating expense margin | 68.5 | % | 76.0 | % | ||||
Operating income (loss) | 169 | (121 | ) | 100 | + | |||
Operating income (loss) margin | 4.9 | % | (3.6 | )% | ||||
Interest expense | 86 | 92 | (7 | ) | ||||
Interest income and investment income, net | 30 | 35 | (14 | ) | ||||
Other components of net periodic benefit cost | 4 | 2 | 100 | |||||
Earnings (loss) before income taxes | 109 | (180 | ) | 100 | + | |||
Provision (benefit) for income taxes | 62 | (24 | ) | 100 | + | |||
Net earnings (loss) | $ | 47 | $ | (156 | ) | 100 | + | |
Net earnings (loss) per common share | ||||||||
Basic | $ | .13 | $ | (.43 | ) | 100 | +% | |
Diluted | $ | .13 | $ | (.43 | ) | 100 | +% | |
Weighted-average common shares outstanding | ||||||||
Basic | 361.2 | 359.6 | ||||||
Diluted | 363.3 | 359.6 | ||||||
(A) Included in net sales, cost of sales and restructuring and other charges are the impacts of returns and charges associated with the restructuring program component of the PRGP and the Post-COVID Business Acceleration Program (the “PCBA Program”). Additional information about the restructuring program component of the PRGP and the PCBA Program is included in the notes to consolidated financial statements in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2025. | ||||||||
(B) From the end of August 2024 through October 2024, the Company reached agreements with certain plaintiff law firms (collectively, the “talcum litigation settlement agreements”) for: (i) the resolution of pending cosmetic talcum powder matters handled by those firms as well as (ii) a process for resolving potential future cosmetic talcum powder claims expected to be brought on behalf of plaintiffs by those firms from January 1, 2025 through December 31, 2029, with annual capped amounts per year for each participating law firm. To account for the talcum litigation settlement agreements, the Company recorded a charge of $159 million in the fiscal 2025 first quarter for the amount agreed to settle the current claims and an estimated amount for potential future claims. |
This earnings release includes some non-GAAP financial measures relating to charges associated with restructuring and other activities and adjustments, as well as organic net sales. Included herein are reconciliations between the non-GAAP financial measures and the most directly comparable GAAP measures for certain consolidated statements of earnings (loss) accounts before and after these items. The Company uses certain non-GAAP financial measures, among other financial measures, to evaluate its operating performance, which represent the manner in which the Company conducts and views its business. Management believes that excluding certain items that are not comparable from period-to-period, or do not reflect the Company’s underlying ongoing business, provides transparency for such items and helps investors and others compare and analyze operating performance from period-to-period. In the future, the Company expects to incur charges or adjustments similar in nature to those presented herein; however, the impact to the Company’s results in a given period may be highly variable and difficult to predict. The Company’s non-GAAP financial measures may not be comparable to similarly titled measures used by, or determined in a manner consistent with, other companies. While the Company considers the non-GAAP measures useful in analyzing its results, they are not intended to replace, or act as a substitute for, any presentation included in the consolidated financial statements prepared in conformity with U.S. GAAP.
The Company operates on a global basis, with the majority of its net sales generated outside the United States. Accordingly, fluctuations in foreign currency exchange rates can affect the Company’s results of operations. Therefore, the Company presents certain net sales information excluding the effect of foreign currency rate fluctuations to provide a framework for assessing the performance of its underlying business outside the United States. Constant currency information compares results between periods as if exchange rates had remained constant period-over-period. The Company calculates constant currency information by translating current-period results using prior-year period monthly average foreign currency exchange rates and adjusting for the period-over-period impact of foreign currency cash flow hedging activities.
Reconciliation between GAAP and Non-GAAP Net Sales | ||||||||
Three Months Ended | Percentage | |||||||
($ in millions) | 2025 | 2024 | ||||||
Net Sales | $ | 3,481 | $ | 3,361 | 4 | % | ||
Non-GAAP Adjustments | ||||||||
Returns associated with restructuring and other activities | (1 | ) | — | |||||
Adjusted Net Sales, Non-GAAP | 3,480 | 3,361 | ||||||
Impact of foreign currency translation | (25 | ) | — | |||||
Organic Net Sales, Non-GAAP | $ | 3,455 | $ | 3,361 | 3 | % |
Reconciliation of Certain Consolidated Statements of Earnings (Loss) Accounts | ||||||||
Three Months Ended | Percentage | |||||||
($ in millions, except per share data) | 2025 | 2024 | ||||||
Gross Profit | $ | 2,554 | $ | 2,433 | 5 | % | ||
Non-GAAP Adjustments | ||||||||
Restructuring and other activities | (3 | ) | 9 | |||||
Adjusted Gross Profit, Non-GAAP | $ | 2,551 | $ | 2,442 | 4 | % | ||
Gross Margin | 73.4 | % | 72.4 | % | ||||
Non-GAAP Adjustments | ||||||||
Restructuring and other activities | (0.1 | ) | 0.3 | |||||
Adjusted Gross Margin, Non-GAAP | 73.3 | % | 72.7 | % | ||||
Operating Income (Loss) | $ | 169 | $ | (121 | ) | 100 | +% | |
Non-GAAP Adjustments | ||||||||
Restructuring and other charges | 86 | 106 | ||||||
Talcum litigation settlement agreements | — | 159 | ||||||
Adjusted Operating Income, Non-GAAP | $ | 255 | $ | 144 | 77 | % | ||
Operating Margin | 4.9 | % | (3.6 | )% | ||||
Non-GAAP Adjustments | ||||||||
Restructuring and other charges | 2.4 | 3.2 | ||||||
Talcum litigation settlement agreements | — | 4.7 | ||||||
Adjusted Operating Margin, Non-GAAP | 7.3 | % | 4.3 | % | ||||
Provision (benefit) for Income Taxes | $ | 62 | $ | (24 | ) | 100 | +% | |
Effective Tax Rate ("ETR") | 56.9 | % | 13.3 | % | ||||
Tax Impact on Non-GAAP adjustments | ||||||||
Restructuring and other charges | 17 | 22 | ||||||
Talcum litigation settlement agreements | — | 35 | ||||||
Adjusted Provision for Income Taxes, Non-GAAP | $ | 79 | $ | 33 | ||||
Adjusted ETR, Non-GAAP | 40.5 | % | 38.8 | % | ||||
Diluted Net Earnings (Loss) Per Common Share | .13 | (.43 | ) | 100 | +% | |||
Non-GAAP Adjustments | ||||||||
Restructuring and other charges | .19 | .23 | ||||||
Talcum litigation settlement agreements | — | .34 | ||||||
Adjusted Diluted Net Earnings Per Common Share, Non-GAAP2 | $ | .32 | $ | .14 | 100 | +% | ||
1Percentages are calculated on an individual basis. | ||||||||
2For the three months ended September 30, 2024, the effects of potentially dilutive stock options, performance share units, and restricted stock units of approximately 1.2 million shares were excluded from the computation of As Reported and adjustments to Non-GAAP diluted loss per common share as they were anti-dilutive due to the net loss incurred during the period. These shares were added to the weighted-average common shares outstanding to calculate Non-GAAP diluted net earnings per common share. |
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited, except where noted) | |||||||||
September 30, | June 30, | September 30, | |||||||
($ in millions) | (Audited) | ||||||||
ASSETS | |||||||||
Cash and cash equivalents | $ | 2,219 | $ | 2,921 | $ | 2,350 | |||
Accounts receivable, net | 1,884 | 1,530 | 1,977 | ||||||
Inventory and promotional merchandise | 2,062 | 2,074 | 2,255 | ||||||
Prepaid expenses and other current assets | 549 | 544 | 633 | ||||||
Total current assets | 6,714 | 7,069 | 7,215 | ||||||
Property, plant and equipment, net | 3,065 | 3,172 | 3,233 | ||||||
Operating lease right-of-use assets | 1,889 | 1,952 | 1,973 | ||||||
Other assets | 7,661 | 7,699 | 8,896 | ||||||
Total assets | $ | 19,329 | $ | 19,892 | $ | 21,317 | |||
LIABILITIES AND EQUITY | |||||||||
Current debt | $ | 3 | $ | 3 | $ | 504 | |||
Accounts payable | 1,289 | 1,497 | 1,135 | ||||||
Operating lease liabilities | 415 | 406 | 393 | ||||||
Other accrued liabilities | 3,376 | 3,529 | 3,454 | ||||||
Total current liabilities | 5,083 | 5,435 | 5,486 | ||||||
Long-term debt | 7,320 | 7,314 | 7,311 | ||||||
Long-term operating lease liabilities | 1,684 | 1,744 | 1,802 | ||||||
Other noncurrent liabilities | 1,352 | 1,534 | 1,634 | ||||||
Total noncurrent liabilities | 10,356 | 10,592 | 10,747 | ||||||
Total equity | 3,890 | 3,865 | 5,084 | ||||||
Total liabilities and equity | $ | 19,329 | $ | 19,892 | $ | 21,317 |
SELECT CASH FLOW DATA | ||||||
Three Months Ended | ||||||
($ in millions) | 2025 | 2024 | ||||
Net earnings (loss) | $ | 47 | $ | (156 | ) | |
Adjustments to reconcile net earnings (loss) to net cash flows from operating activities: | ||||||
Depreciation and amortization | 200 | 208 | ||||
Deferred income taxes | (34 | ) | (79 | ) | ||
Other items | 82 | 73 | ||||
Changes in operating assets and liabilities: | ||||||
Increase in accounts receivable, net | (358 | ) | (219 | ) | ||
Decrease (increase) in inventory and promotional merchandise | 6 | (10 | ) | |||
Increase in other assets, net | (11 | ) | (47 | ) | ||
Decrease in accounts payable and other liabilities, net | (272 | ) | (440 | ) | ||
Net cash flows used for operating activities | $ | (340 | ) | $ | (670 | ) |
Other Investing and Financing Uses: | ||||||
Capital expenditures | $ | (96 | ) | $ | (141 | ) |
Dividends paid to stockholders | (127 | ) | (240 | ) | ||
Payment of deferred consideration | (150 | ) | — | |||
Supplemental cash flow information: | ||||||
Cash paid for interest | $ | 62 | $ | 63 | ||
Cash paid for income taxes | 148 | 195 |
Operating results by geographic region for the fiscal 2025 first quarter, as presented above, have been adjusted to reflect the correction of a regional misclassification in the amounts furnished in the Form 8-K on October 2, 2025 related to a one-time charge during the fiscal 2025 first quarter. The misclassification was offset in the fiscal 2025 second quarter (quarter-to-date period) furnished amounts, and the adjusted amounts are presented below. No other periods were impacted and there is no impact on the consolidated financial results or results by product category.
Results by Geographic Region | ||||||||||||||||||||
Three Months Ended December 31 | ||||||||||||||||||||
Net Sales | Percentage Change1 | Operating (Loss) | Percentage | |||||||||||||||||
($ in millions) | 2024 | 2023 | Reported | Impact of | Organic | 2024 | 2023 | Reported | ||||||||||||
The Americas | $ | 1,209 | $ | 1,239 | (2 | )% | 1 | % | (1 | )% | $ | (771 | ) | $ | 145 | (100 | +)% | |||
EUKEM | 1,085 | 1,064 | 2 | — | 2 | 145 | 103 | 41 | ||||||||||||
Asia/Pacific | 888 | 1,069 | (17 | ) | 1 | (16 | ) | 152 | 214 | (29 | ) | |||||||||
Mainland China | 822 | 908 | (9 | ) | (1 | ) | (10 | ) | 75 | 120 | (38 | ) | ||||||||
Subtotal | $ | 4,004 | $ | 4,280 | (6 | )% | — | % | (6 | )% | $ | (399 | ) | $ | 582 | (100 | +)% | |||
Returns/charges | ||||||||||||||||||||
associated with | ||||||||||||||||||||
restructuring and | ||||||||||||||||||||
other activities | — | (1 | ) | (181 | ) | (8 | ) | |||||||||||||
Total | $ | 4,004 | $ | 4,279 | (6 | )% | — | % | (6 | )% | $ | (580 | ) | $ | 574 | (100 | +)% | |||
Non-GAAP Adjustments to As Reported Operating (Loss) Income: | ||||||||||||||||||||
Returns/charges associated with restructuring and other activities | 181 | 8 | ||||||||||||||||||
The Americas - Goodwill and other intangible asset impairments | 861 | — | ||||||||||||||||||
The Americas - Change in fair value of DECIEM acquisition-related stock options | — | (5 | ) | |||||||||||||||||
Adjusted Operating Income - Non-GAAP | $ | 462 | $ | 577 | (20 | )% | ||||||||||||||
1Percentages are calculated on an individual basis. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20251030442112/en/
Bank
Analyser
Aktieråd
Rapporter


Bank
Analyser
Aktieråd
Rapporter


1 DAG %
Senast

OMX Stockholm 30
1 DAG %
Senast
2 767,07